Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov 6;14:1289198. doi: 10.3389/fimmu.2023.1289198

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Wang, Wang, He, Ji, Pang, Wang, Liu and Ren

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Tissue microarray analysis confirms high expression of PRPF19 in bladder cancer and its prognostic value. (A–D) Expression of PRPF19 in bladder cancer and normal tissues analyzed by immunohistochemical staining. (E) Expression of PRPF19 in paired bladder cancer tissues. (F) Expression of PRPF19 in 56 bladder cancer tissues and 32 normal bladder tissues. (G) Analysis of the difference in survival time between patients in the high PRPF19 expression group and low PRPF19 expression group. (H) Analysis of the ratio of survival/death of patients in the high PRPF19 expression group and low PRPF19 expression group. (I) Trends in the distribution of bladder cancer patients by age, sex, and other clinical factors. (J) Kaplan-Meier survival analysis of PRPF19 expression. (K–M) Analysis of the predictive ability of PRPF19 expression on the 1,3,5-year prognosis of bladder cancer patients. **p < 0.01 and ***p < 0.001.